Monoclonal Antibody Therapeutics Market will generate new growth opportunities 2024-2031 | Pfizer Inc., Novartis AG
BURLINGAME, CALIFORNIA, UNITED STATES, February 26, 2024 /EINPresswire.com/ -- The "Monoclonal Antibody Therapeutics Market was valued for $6.5 billion in 2024 and is estimated to reach $18.5 billion by 2031, exhibiting a CAGR of 11.2% from 2024 to …